首页> Neurodegenerative disease management> A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study.

A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Gavin,Giovannoni

第一单位： Blizard Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.

作者： Gavin,Giovannoni ^[1] ; Alexey,Boyko ^[2] ; Jorge,Correale ^[3] ; Gilles,Edan ^[4] ; Mark S,Freedman ^[5] ; Xavier,Montalban ^[6] ; Kottil,Rammohan ^[7] ; Dusan,Stefoski ^[8] ; Bassem,Yamout ^[9] ; Thomas,Leist ^[10] ; Aida,Aydemir ^[11] ; Laszlo,Borsi ^[12] ; Elisabetta Verdun,di Cantogno ^[11]

作者单位： Blizard Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, UK. ^[1] Pirogov Russian National Research Medical University, Department of Neurology, Neurosurgery & Medical Genetics, Federal Center of Brain Research & Neurotechnologies, Moscow, Russia. ^[2] Department of Neurology, FLENI Institute, Buenos Aires, Argentina. ^[3] Department of Neurology, University Hospital of Rennes, Rennes, France. ^[4] University of Ottawa, Department of Medicine & the Ottawa Hospital Research Institute, Ottawa, ON, Canada. ^[5] Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d'Hebron, Barcelona, Spain. ^[6] University of Miami School of Medicine, MS Research Center, Miami, FL, USA. ^[7] Department of Neurological Sciences, Rush Medical College, Chicago, IL, USA. ^[8] Neurology Institute, Harley Street Medical Center, Abu Dhabi, UAE.;American University of Beirut Medical Center, Beirut, Lebanon. ^[9] Division of Clinical Neuroimmunology, Jefferson University, Comprehensive MS Center, Philadelphia, PA, USA. ^[10] EMD Serono Research & Development Institute, Inc., Billerica, MA, USA (an affiliate of Merck KGaA). ^[11] Merck Healthcare KGaA, Darmstadt, Germany. ^[12]

关键词 cladribine tablets (Mavenclad?)lay summary mobility multiple sclerosis relapses

医学主题词人类(Humans);克利屈滨(Cladribine);多发性硬化(Multiple Sclerosis);免疫抑制剂(Immunosuppressive Agents);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting);片剂(Tablets);复发(Recurrence)

DOI 10.2217/nmt-2023-0018

PMID 37535336

发布时间 2025-09-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交